Forest Laboratories Inc. said it is buying specialty pharmaceutical company Clinical Data Inc. in a $1.2 billion deal in order to gain access to a key antidepressant.
Synbiosis, a leading manufacturer of automated microbiological systems, will debut its ProtoCOL 2 automated colony counting and zone measurement system for quick and easy analysis of standard and large plates at ArabLab 2011.
Shimadzu Scientific Instruments introduces the TOC-L Series of analyzers for total organic carbon testing in aqueous samples. With a wide sample range from 4 ?g/L to 30,000 mg/L, the TOC-L is suitable for analyzing ultra-pure to highly contaminated samples of pharmaceutical water.
Scientists have pinpointed a key cancer-causing gene that, when overactive, triggers a particularly aggressive type of breast cancer to develop. This is the first time in over five years that scientists have discovered a new breast cancer "oncogene".
Unrealistic expectations about genomic medicine have created a "bubble" that needs deflating before it puts the field's long term benefits at risk, four policy experts write in the current issue of the journal Science.
The ErbB, or epidermal growth factor receptor, tyrosine kinase family plays a crucial role in regulating cell proliferation, differentiation, motility, and apoptosis, which contribute to pathological processes such as cancer.
Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd., announced that the U.S. Food and Drug Administration has approved ABILIFY as an adjunct to the mood stabilizers lithium or valproate for the maintenance treatment of bipolar I disorder.
Swiss drugmaker Novartis said a European advisory committee gave a positive recommendation for its blood pressure treatment Rasilamlo. The pill aims to treat high blood pressure that is not adequately controlled by either aliskiren or amlodipine alone.
Almac’s newly launched Bioinformatics consultancy supports discovery and development of biomarkers as well as enabling an in-depth understanding of biology by partnering with customers in the pharmaceutical, biotech, and diagnostics setting.
West Virginia Health Right has received a three-year grant worth $556,957 to fund a healthy heart program for its 34-county coverage area, officials announced.
GE Healthcare announced that on April 1, 2011, Kieran Murphy will be promoted to succeed current Life Sciences President and CEO Peter Ehrenheim who will retire from GE after a transition period on July 31, 2011.
A fired employee who admitted stealing trade secrets from Bristol-Myers Squibb Co. in a plot to launch a pharmaceutical business in his native India has been sentenced to a year he's already served in jail in upstate New York.
Supercritical fluid chromatography has begun taking on new roles in the pharmaceutical industry.
Joint development of investigational drugs could speed combination drugs to market, if legal issues don’t overwhelm scientific challenges.